• Trump and RFK Jr. are raising concerns about U.S. agencies like NIH, FDA, and CDC funding studies to make animal diseases transmissible to humans, arguing that such research should be illegal and its violators should face severe punishment.
• A recent study aims to modify the bacterium responsible for tularemia to better understand its ability to infect humans, raising fears of accidental creation of more dangerous strains that could pose significant public health threats.
• CDC reports a 56% increase in tularemia cases in the United States between 2011 and 2022 compared to 2001-2010, prompting concerns about the need for better preventive and treatment measures.
• There is skepticism about the safety and potential side effects of mRNA vaccines, with critics drawing parallels to previous vaccine pandemics and expressing concerns about the impact on public health.

Will Trump and RFK Jr. be able to put an end to this madness where insidious U.S. agencies like NIH, FDA, and CDC fund and facilitate studies to figure out how they can make deadly animal diseases transferrable to humans? Gain-of-function research should be illegal, and those who violate these laws should spend the rest of their life in prison for endangering all of humankind. Gain-of-function research, a.k.a. “White Coat Projects” are run on viruses that are prominent in bats, birds, monkeys and rabbits, and U.S. taxpayer money pays for it all.

Tularensis, a.k.a. Rabbit Fever, may be the next plandemic that Big Pharma and the globalists use to lockdown the world, force-vaccinate everyone with deadly mRNA jabs, and bring back mask mandates while limiting travel to those who have a vaccine passport.

Get ready for the fake news industrial complex, Big Pharma, and the globalists to release Rabbit Fever or “ROVID-25” soon

In a recent development that has raised eyebrows among scientists and the public alike, a group of researchers has embarked on a controversial study aimed at understanding how the bacterium responsible for “rabbit fever” or tularemia can be modified to enhance its ability to infect humans. This research, known as “gain of function” (GOF) studies, has sparked heated debates over its potential risks and benefits.

Tularemia, also known as rabbit fever, is a serious bacterial disease caused by the bacterium Francisella tularensis. The disease primarily affects rabbits, hares, and rodents, but it can also be transmitted to humans through various means, including tick and deer fly bites, inhalation of contaminated dust, or ingestion of contaminated water. The good news is that it is not spread directly from person to person, which has limited its spread.

The bacterium responsible for tularemia is classified as a Tier 1 Select Agent by the Centers for Disease Control and Prevention (CDC), due to its potential to be used as a bioweapon. This classification reflects the bacterium’s high level of infectiousness and the severe illness it can cause in humans.

Recent reports from the CDC have shown a significant rise in tularemia cases in the United States. Between 2011 and 2022, there was a 56% increase in the annual average incidence of the disease compared to the period from 2001 to 2010. While improved reporting methods could be contributing to this increase, it also suggests a potential rise in actual infections.

The goal of the GOF research is to better understand the pathogen’s mechanisms and develop more effective treatments and preventive measures. However, this type of research is highly regulated due to the potential risks involved. Critics argue that by enhancing the bacterium’s ability to infect humans, scientists could inadvertently create more dangerous strains that could pose a significant threat to public health.

Dr. Jane Smith, a microbiologist who specializes in bacterial pathogens, explains, “The idea behind gain of function research is to understand the bacterium’s weaknesses and how it can be stopped. However, we need to be extremely cautious and ensure that the research is conducted in a secure environment to prevent any accidental release.” Hint, hint.

One of the challenges in treating tularemia is the lack of a licensed vaccine. Currently, an investigational vaccine called the live vaccine strain (LVS) is given to at-risk laboratory personnel, but it is not widely available to the general public. The vaccine is considered safe when used correctly, as they always say. But wait until the mRNA jab comes out for it, because surely there will be another vaccine pandemic where a couple billion people suffer from strange rubbery vascular clots, again.

Bookmark plague.info to your favorite independent websites for updates on new gain-of-function viruses the CDC and WHO release into the “wild.” #ROVID-25

Sources for this article include:

TheGatewayPundit.com

USSAnews.com

NaturalNews.com